Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
TriSalus Life Sciences, Inc. (TLSI) had Weighted-Average Shares Outstanding (Diluted) of 37.90M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$45.15M |
|
$-69.69M |
|
$6.96M |
|
$38.19M |
|
$72.10M |
|
$-26.95M |
|
$-12.27M |
|
$-39.22M |
|
$-39.22M |
|
$-39.21M |
|
$-39.21M |
|
$-39.23M |
|
$-39.21M |
|
$-26.95M |
|
$-25.27M |
|
37.90M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
37.90M |
$-1.84 |
|
$-1.84 |
|
| Balance Sheet Financials | |
$32.24M |
|
$1.81M |
|
$3.09M |
|
$35.33M |
|
$11.50M |
|
$33.05M |
|
$57.69M |
|
$69.19M |
|
$-33.86M |
|
$-33.86M |
|
$-33.86M |
|
50.00M |
|
| Cash Flow Statement Financials | |
$-18.01M |
|
$-0.84M |
|
$30.76M |
|
$8.88M |
|
$20.79M |
|
$11.91M |
|
$9.13M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.80 |
|
-- |
|
-- |
|
-40.55 |
|
-0.98 |
|
84.57% |
|
-59.68% |
|
-59.68% |
|
-55.97% |
|
-86.86% |
|
-154.35% |
|
$-18.85M |
|
-- |
|
-- |
|
-- |
|
1.28 |
|
2.26 |
|
6.88 |
|
53.01 |
|
115.81% |
|
115.81% |
|
-110.99% |
|
4811.42% |
|
$-0.68 |
|
$-0.50 |
|
$-0.48 |
|